Opinion
MDL 3094 CIVIL ACTION 24-md-3094
10-17-2024
IN RE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) PRODUCTS LIABILITY LITIGATION ALL ACTIONS/ALL CASES
ORDER
KAREN SPENCER MARSTON, J.
AND NOW, this 17th day of October, 2024, upon consideration of Plaintiffs' Motion to Permit Marketing Discovery or to Reconsider Order Precluding Marketing Discovery (Doc. No. 245), Defendants' opposition brief (Doc. No. 254), Plaintiffs' reply brief (Doc. Nos. 256, 271), and the arguments made by counsel during status conferences on September 23, 2024 and October 15, 2024, it is ORDERED that the motion is DENIED.
IT IS SO ORDERED.